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The rat UCP1 (uncoupling protein 1) is a mitochondrial inner-
membrane carrier involved in energy dissipation and heat pro-
duction. We expressed UCP1 carrying a His6 epitope at its
C-terminus in Saccharomyces cerevisiae mitochondria. The
recombinant-tagged UCP1 was purified by immobilized metal-
ion affinity chromatography to homogeneity (>95%). This made
it suitable for subsequent biophysical characterization. Fluo-
rescence resonance energy transfer experiments showed that n-
dodecyl-β-D-maltoside-solubilized UCP1–His6 retained its PN
(purine nucleotide)-binding capacity. The far-UV CD spectrum
of the functional protein clearly indicated the predominance of
α-helices in the UCP1 secondary structure. The UCP1 secondary
structure exhibited an α-helical degree of approx. 68%, which
is at least 25% higher than the previously reported estimations
based on computational predictions. Moreover, the helical content
remained unchanged in free and PN-loaded UCP1. A homology
model of the first repeat of UCP1, built on the basis of X-ray-
solved close parent, the ADP/ATP carrier, strengthened the CD
experimental results. Our experimental and computational results
indicate that (i) α-helices are the major component of UCP1
secondary structure; (ii) PN-binding mechanism does not involve
significant secondary-structure rearrangement; and (iii) UCP1
shares similar secondary-structure characteristics with the ADP/
ATP carrier, at least for the first repeat.
Key words: CD, fluorescence resonance energy transfer, homo-
logy modelling, mitochondrial membrane protein, secondary
structure, uncoupling protein.
INTRODUCTION
UCP1 (uncoupling protein 1) is a mitochondrial inner-membrane
protein found in thermogenic brown adipocytes and belongs to
the large MCF (mitochondrial carrier family) [1]. It dissipates
energy into heat by catalysing the re-entry of protons of the
electrochemical gradient built up by the respiratory chain (see [2]
for a review). Its function is activated by NEFA (non-esterified
fatty acid) and is inhibited by PNs (purine nucleotides). Moreover,
its activity seems to depend on the presence of coenzyme Q,
a redox intermediate of the respiratory chain. The latter may
act as an obligatory cofactor for UCP1 activity [3]. However,
the mechanism of the NEFA-mediated proton import and its
regulation need to be elucidated at the molecular level.
To date, very little structural information is available for the
UCP1 as well as for other UCP subfamily members. This is
mainly due to the difficulty in obtaining large amounts of native,
i.e. functional, protein purified to homogeneity. Similar to the
other members of the MCF, the nuclear-encoded UCP1 gene
exhibits a triplicated structure leading to a 3-fold repeat of approx.
100 amino acids. According to the sequence alignments and
the hydrophobicity profiles, it has been hypothesized that these
three domains have related sequences yielding similar secondary
structures. A widely accepted model proposed by Runswick
et al. [4] has finally emerged from computational analyses of
UCP1, AAC (ADP/ATP carrier) and phosphate carrier sequences
and has been further extended to all members of the MCF.
This model suggests that six membrane-spanning α-helices, two
in each domain, are connected by large loop protrusions of
undefined secondary structure that are consecutively located at
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the matrix and cytosol sides [5]. This topological model has
been strengthened by the study of antigenic sites conducted on
UCP1 by Miroux et al. [6]. On the basis of hydrophobicity
profiles and considering a minimized number of polar residues
in helix segments due to energy constraints, membrane-spanning
helices were defined with an average length of 19 and 21 residues
respectively within odd- and even-numbered helices [7,8]. Thus
approx. 120 residues are suspected to adopt a helical conform-
ation; hence a helical degree of approx. 40% can be deduced.
Recently, the X-ray structure of the mitochondrial AAC1, a
member of the MCF, has been obtained at 2.2 Å (1 Å = 0.1 nm)
resolution in the carboxyatractyloside-inhibited conformation [9].
When AAC1 secondary-structure contents calculated from X-ray
crystallography and from computational predictions are com-
pared, numerous structural differences can be pointed out. Indeed,
lengths of odd- and even-numbered helices as well as the presence
of small hydrophilic helices within the three-matricial loops have
been badly predicted from hydropathy profiles of the primary
structure. Both transmembrane domains and hydrophilic helices
actually increase the helical content to 66% (195/297 amino
acids), which is at least 25% more than the previous predicted
model.
In contrast with other eukaryotic cells, no homologue of
UCP1 is found in yeast Saccharomyces cerevisiae mitochondria.
Therefore recombinant UCP expressions have been previously
achieved in S. cerevisiae [10]. After the induction of the phospho-
glycerate kinase promoter-controlled expression (pKV49 vector),
strong expression has led to a marked growth defect of the yeast
[11] and, at the highest expression level, to a mitochondrial
‘uncoupling artifact’, i.e. a PN-insensitive NEFA-stimulated
c© 2004 Biochemical Society
140 P. Douette and others
proton leak. This phenomenon has been putatively linked to the
rate of UCP1 synthesis [12].
In the present study, a yeast-based expression system has been
used to produce and purify sufficient quantities of UCP1 for
subsequent biophysical characterization. Furthermore, we report
a new expression and purification strategy that leads to a
homogeneous and functional UCP1. Thus we have expressed
UCP1 carrying a His6 epitope at its C-terminus in the yeast S.
cerevisiae, at a mild level that does not lead to an artifactual
uncoupling described with the pKV49 vector. After detergent
solubilization, purification of the yeast-expressed UCP1–His6
was performed to homogeneity by a two-step strategy including
an HTP (hydroxyapatite) step followed by IMAC (immobilized
metal-ion affinity chromatography). We probed the GTP-binding
capacity of the detergent-solubilized purified protein by FRET
(fluorescence resonance energy transfer). The secondary-structure
content of both GTP-free and GTP-inhibited UCP1 has been
determined by far-UV CD analysis. Analysis of these results
clearly demonstrates that high helical content is the major
structural feature of UCP1, which is not modified by PN binding.
EXPERIMENTAL
Chemicals
DDM (n-dodecyl β-D-maltoside) Anagrade was purchased from
Anatrace (Maumee, OH, U.S.A.), membrane protein grade
TX100 (Triton X-100) was from Roche and Mant (N-methyl-
anthraniloyl)-ATP was from Molecular Probes. BSA, ATP and
GTP were purchased from ICN Biomedicals (Asse-Relegem,
Belgium). CHT Ceramic HTP type II was purchased from Bio-
Rad Laboratories and Ni-NTA (Ni2+-nitrilotriacetate) resin was
from Novagen. Devices for dialysis were purchased from Pierce
(Slide-A-Lyzer Dialysis cassette, 10 000 Da molecular mass cut-
off). All other reagents were of the highest purity grade.
Protein expression in S. cerevisiae
After PCR amplification, rat UCP1 gene (kindly provided by
Dr F. Bouillaud, Centre National de la Recherche Scientifique,
Meudon, France) was inserted into pYES 2.1/Topo TA cloning
vector (Invitrogen) containing the URA3 gene for selection
and GAL1 promoter and enhancer for a galactose-inducible
expression. The forward primer (5′-AACAAAATGGTGAGTT-
CGACAACTTCC-3′) contained a Kozak sequence (underlined)
at the translation initiation site to increase the translation of the
protein [13]; the reverse primer [5′-CTA-(ATG)6-TGTGGTGC-
AGTCCACTGT-3′] contained the sequence coding for the His6
tag (underlined) to allow the affinity purification of UCP1–
His6 on IMAC. After verifying the sequence of the insert (ALF
Express, Amersham Biosciences), the plasmid was transformed
into Escherichia coli Top10F′ strain, purified and subcloned into
S. cerevisiae diploid INVSc1 (a/α) strain (Invitrogen).
Cultures were grown in either 2 litre flasks or 15 litre fermenter
(BioFlow 4500; New Brunswick Scientific, Rotselaar, Belgium)
after 48 h precultures (100 ml and 1 litre respectively). Expression
was induced for 4–16 h. The preculture was conducted in SC
(S. cerevisiae) minimal medium containing 0.67% (w/v) yeast
nitrogen base, 0.25% (w/v) (NH4)2SO4, 0.01 or 0.05% (w/v)
amino acids and 2% (w/v) glucose. Glucose repressed GAL1-
promoted gene expression. Induction medium was the one used
for preculture, except for the carbon source that was 2% (w/v)
galactose.
Cells were harvested from 15 litre fermenters with a D600
of approx. 8.0. Mitochondria were isolated after the generation of
spheroplasts by zymolyase 20T (ICN Biomedicals), as described
by Daum et al. [14]. During NEFA-depleting steps, BSA concen-
tration varied from 0.1 to 1% (w/v) from one flask preparation
to another. BSA was removed by two washing steps in 20 mM
Tris and 0.65 M mannitol (pH 7.5), and mitochondria were resus-
pended into the same buffer at a final concentration of 50 mg/ml.
Mitochondrial respiration (1 mg of mitochondrial protein) was
assayed at 25 ◦C using a Clarck-type electrode (Hansatech, King’s
Lynn, Norfolk, U.K.) in respiration buffer (10 mM Tris/0.65 M
mannitol/0.5 mM EGTA/ 2 mM MgCl2/10 mM KH2PO4, pH 6.9)
containing 2 mM NADH and 1 mM succinate. Mitochondrial
UCP1–His6 content was evaluated by Western blotting (using
anti-His-tagged antibodies) with purified UCP1–His6 as a
standard.
Protein purification
Typically, 50 mg of mitochondrial proteins was solubilized at a
final concentration of 10 mg/ml in 20 mM Tris, 20 mM Na2SO4,
0.25 mM EDTA, protease inhibitor cocktail (pH 6.8) supple-
mented with 1–2% (w/v) TX100. After 1 h of incubation at 4 ◦C,
the mitochondrial sample was centrifuged at 20 000 g for 20 min
at 4 ◦C. The supernatant was then applied on HTP resin at a flow
rate of 2 ml/min using an Åkta Station (Amersham Biosciences;
10 mg of total protein/ml of settled gel, equilibrated with 5 mM
Tris, 20 mM Na2SO4, 0.25 mM EDTA and 0.05% TX100).
UCP1–His6 and also two major contaminants did not bind the resin
and were recovered in the flow-through fraction. HTP fraction
was supplemented with 50 mM NaH2PO4/Na2HPO4, 100 mM
NaCl and 1 mM MgCl2, and applied on Ni-NTA resin (Novagen)
equilibrated in 50 mM NaH2PO4/Na2HPO4, 100 mM NaCl and
0.05% TX100. The final protein amount/resin volume ratio was
set to 1. The batch incubation was performed for 2 h at 4 ◦C
under stirring. The resin was mounted on to a small column
and washed with 100 resin vol. of washing buffer containing
20 mM Tris, 100 mM NaCl, 20 mM imidazole and 0.02–0.05%
of detergent (TX100 or DDM; see the Results and Discussion
section). The protein was finally eluted at a final concentration
of 0.2–0.4 mg/ml in washing buffer supplemented with 500 mM
imidazole. Imidazole was removed by extensive dialysis. Protein
concentration was determined with DC Protein assay kit (Bio-Rad
Laboratories).
SDS/PAGE and Western blotting
Proteins were subjected to electrophoresis in 8 or 10% SDS/
polyacrylamide gel and analysed by Coomassie Blue staining or
Western blotting. Western blotting was performed with a Trans-
blot semi-dry transfer cell (Bio-Rad Laboratories). Proteins were
transferred to PVDF membrane (Immobilon-P; Millipore) and
revealed by using BM Chemiluminescence Western blotting kit
(Roche). Briefly, the membrane was blocked for 1 h at room
temperature (20 ◦C) in blocking buffer [50 mM Tris/100 mM
NaCl, pH 7.5/1% (v/v) blocking reagent], incubated for 1 h
at room temperature with anti-His6 antibody coupled with
peroxidase (Roche), washed three times in 50 mM Tris, 100 mM
NaCl (pH 7.5), 0.1% (v/v) Tween 20 and finally exposed for
10 s to 1 min to Hyperfilm ECL® (Amersham Biosciences). Pro-
tein content estimations on Coomassie Blue-stained gels and auto-
radiographed films were performed with NIH ImageJ software.
FRET and nucleotide-binding measurement
The PN-binding capacity of isolated UCP1–His6 was assayed by
FRET in a PerkinElmer LS50B spectrofluorimeter. Excitation
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and emission wavelengths were 280 and 435 nm respectively
with slit widths of 3 and 5 nm respectively and the scan speed
was 100 nm/min. FRET experiments were performed in 100 µl
microcuvettes (Hellma, Mu¨llheim, Germany), with a path length
of 0.3 cm. Fluorescence of 10 µM Mant-ATP was measured at
room temperature in the presence of 150 µg/ml purified UCP1
(approx. 5 µM). The buffer contained 10 mM Tris, 100 mM NaCl
(pH 6.8) and 0.05% DDM. Binding equilibrium was displaced
by adding 1 mM unmodified ATP. For each sample, five spectra
were collected, averaged and baseline-corrected by subtraction of
blank buffer.
CD measurements
Before CD analysis, DDM-solubilized purified UCP1–His6 was
extensively dialysed (three times, 100 vol. of sample) against
5 mM Tris and 0.03% DDM (pH 6.8).
CD measurements were made in a Jasco J-810 spectropolari-
meter, in the amide band (190–240 nm) at a protein concentration
of 150 µg/ml (approx. 5 µM). Spectra were acquired in a 0.1 cm
cell path length at a scan speed of 20 nm/min, with a 1 nm
bandwidth and a 4 ms response. The spectra were measured 10-
fold, averaged and baseline-corrected by subtraction of blank
buffer. For measurements, performed in the presence of GTP,
a high-GTP concentration stock (100 mM) was used to avoid
protein dilution and the mixture was left to equilibrate for 5 min
before CD recording.
The far-UV CD spectra were analysed on DichroWeb web-
site [15,16], using CDSSTR [17,18] and SELCON3 [19,20]
algorithms, with the basis set including CD spectra of 43 globular
proteins of solved structure [21]. The SVD (singular-value decom-
position) algorithm assigned native and GTP-inhibited UCP1
secondary structures.
Homology modelling
Sequence alignments of rat UCP1 and bovine heart AAC1
(SwissProt accession nos P04633 and P0272 respectively) were
performed with ClustalW. The length of UCP1 repeats was
determined either by internal alignment of UCP1 repeats or by
UCP1/AAC1 alignment. The automated comparative modelling
server Swiss-Model located at ExPASY was employed to generate
a model of UCP1 repeat 1 with AAC1 structure as the template
(PDB accession no. 1OKC). The model reliability was determined
on the basis of Cα RMSD (root mean square deviation).
RMSD values were calculated with Swiss-PDB Viewer [22].
PROCHECK [23] was used to calculate the secondary structure
from PDB files.
RESULTS AND DISCUSSION
Expression of UCP1–His6 in yeast mitochondria
To enable purification of UCP1 to homogeneity, we exploited
IMAC approach after introducing six histidine residues at the C-
terminus of the protein. The addition of the C-terminal epitope
was achieved by PCR amplification as well as a Kozak sequence.
Since we were looking for a mild expression to avoid artifactual
uncoupling due to high-level expression of recombinant UCP1
in yeast [12], GAL1 promoter, inducible on galactose addition,
was used. The yeast-expressed UCP1–His6 exhibited an expected
36 kDa band, which was revealed by Coomassie Blue (Figure 1A).
After overnight induction with 2% galactose at 28 ◦C, total
mitochondrial proteins were analysed by Western blotting with
antibodies directed against the His epitope. In these expression
conditions, expression level was evaluated to approx. 10 µg/mg
Figure 1 Analysis of UCP1–His6 expression in yeast mitochondria and LA-
stimulated GTP-sensitive uncoupling activity on isolated mitochondria
(A) Total mitochondrial proteins (50 µg/lane) from isolated mitochondria were subjected to
SDS/PAGE (12 % gel) and analysed by Coomassie Blue staining. Yeast mitochondria were
isolated from non-induced culture (lane 1) or from culture induced with 2 % galactose for
16 h at 28 ◦C (lane 2). A marked band (arrow) appeared at approx. 36 kDa corresponding to
UCP1–His6. M, molecular-mass standards (kDa). (B) Mitochondria (1 mg) were incubated at
25 ◦C with a respiration buffer containing 2 mM NADH and 1 mM succinate in the absence
or presence of GTP as mentioned. Successive additions of LA (final concentrations of 1, 2, 5
and 10 µM, downward-pointing arrows) led to an increase in respiration rate in the absence of
GTP. NEFA removal was achieved by a final addition of 0.1 % BSA (downward-pointing arrow).
Numbers on the traces refer to respiration rates in nmol of oxygen · min−1 · (mg of protein)−1.
of total mitochondrial proteins. Moreover, this expression level
did not induce a strong growth defect of the culture but only a
slow down of 15–20% (results not shown).
After 16 h of induction with 2% galactose, the isolated mito-
chondria showed an NEFA-activated PN-sensitive uncoupling
activity. Indeed, increasing concentrations of LA (linoleic acid)
stimulated non-phosphorylating respiration, and the presence of
an UCP1 inhibitor, such as GTP, cancelled this LA-sustained
respiration (Figure 1B). The non-phosphorylating respiration was
stimulated 2.5-fold by 10 µM LA due to uncoupling activity and
was fully inhibited by the addition of 2 mM GTP. Regarding
the higher initial respiration rate in the absence of PN, we
assumed that endogenous NEFA content in isolated mitochondria
remained high. Interestingly, this NEFA-induced UCP1 activity
was detectable even at the highest BSA concentration (1%) used
in depletion buffers during mitochondrial preparations and was
fully inhibited by the addition of GTP. Moreover, final addition
of 0.1% BSA in the absence of GTP led to the same respiration
rate similar to the condition where GTP inhibited the uncoupling
activity. This emphasized that no artifactual uncoupling was
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Figure 2 TX100 and DDM purification procedure of UCP1–His6 from 40 mg
of total mitochondrial proteins
(A) Proteins isolated from successive purification steps were subjected to SDS/PAGE (10 % gel)
and analysed by Coomassie Blue staining: TX100-solubilized supernatant (10 µg, lane 1); HTP
flow-through (5 µg, lane 2); supernatant after 2 h of incubation with Ni-NTA resin (5 µg, lane 3);
and pure TX100-eluted fraction after treatment of the Ni-NTA resin with buffer containing 500 mM
imidazole (5 µg, lane 4). (B) The same procedure was applied to UCP1–His6 with exchange of
0.05 % DDM during IMAC washing step (5 µg, lane 5). Lane M, molecular mass markers (kDa).
detected during non-phosphorylating respiration experiments.
Stuart et al. [12] expressed similar amounts of UCP1 in yeast
using a stronger promoter, the phosphoglycerate kinase promoter
(pKV49 vector), but without fusion of UCP1 gene to a Kozak
sequence that favours translation in eukaryotic cells. Under this
expression condition, they demonstrated an NEFA-induced PN-
insensitive uncoupling and assigned this artifactual proton leak as
a function of the rate of UCP1 synthesis. However, in the present
study, no significant artifactual GTP-insensitive LA-stimulated
respiration was detected when GTP was present to inhibit UCP1.
This might be explained by our specific conditions of expression,
i.e. a mild promoter together with an upstream Kozak sequence
instead of a stronger promoter in the absence of a translation
enhancer.
UCP1–His6 uncoupling activity measured on isolated mito-
chondria allowed us to assess whether the His epitope inter-
fered with the UCP1 function and thus affected the native struc-
ture. Measurements of non-phosphorylating respiration clearly
demonstrated that UCP1–His6 is sensitive to one NEFA activator
(LA) and one of its inhibitors (GTP).
Purification of UCP1–His6 and nucleotide-binding measurement
UCP1 was purified earlier using solubilization and HTP steps in
the presence of TX100 detergent. This procedure led to a partially
pure protein suitable for subsequent functional characterizations
and reconstitution experiments [24,25]. Nevertheless, we had to
ensure exclusion of co-purification of any other mitochondrial
proteins to envisage further biophysical analyses. Accordingly,
we first developed a simple and reliable purification procedure
for recombinant UCP1 expressed in yeast mitochondria. We used
a nickel-chelating affinity-chromatography step, which signi-
ficantly eased and accelerated purification of the recombinant
His-tagged UCP1 to homogeneity.
A three-step procedure was used, which included the conven-
tional procedure (solubilization and HTP chromatography, [24])
for isolation of UCP followed by an IMAC step (Figure 2A).
When applied to the HTP column, the TX100-solubilized UCP1
was first collected in the flow-through together with two major
contaminants. Solubilization conditions of mitochondria that gave
maximal yield of UCP1–His6 in the HTP supernatant were with
a protein/detergent (w/w) ratio of 2. Then the IMAC batch
procedure allowed us to achieve high-grade purification of the
UCP1–His6 isolated from the HTP. After 2 h of batch incubation
with the resin and extensive washing in the presence of 20 mM
Figure 3 FRET experiments showing Mant-modified ATP binding to UCP1–
His6 and competition with unmodified nucleotide
Maximum Mant-ATP fluorescence peak was at approx. 435 nm. Fluorescence emission spectra
(λex = 280 nm) were recorded in (5) 10 mM Tris, 100 mM NaCl (pH 6.8) and 0.05 % DDM
containing (1) 5 µM UCP1–His6 and 10 µM Mant-ATP, (2) 5 µM UCP1–His6, 10 µM Mant-
ATP and 1 mM ATP, (3) 5 µM UCP1–His6 and (4) 10 µM Mant-ATP. FU, fluorescence units.
imidazole, maximal recovering yields were obtained with two
repeated treatments (1 vol. of resin each) of buffer containing
500 mM imidazole. Moreover, UCP1–His6 was typically eluted
at a final protein concentration range of 0.2–0.4 mg/ml. It is
noteworthy that 20 mM imidazole allowed removal of the major
contaminants but did not unbind the tagged protein, which
demonstrated an efficient affinity of UCP1–His6 for the Ni-NTA
resin in contrast with the reported purification procedure of His-
tagged AAC expressed in yeast [26]. Highly purified UCP1–His6
(0.25 +− 0.06 mg; S.D. calculated on the basis of five independent
preparations) was recovered from 40 mg of starting mitochondrial
material. As for the estimated expression level, we assumed that
approx. 40% of UCP1–His6 was lost during the purification
procedure. Since no other proteins were detected on Coomassie
Blue-stained gel, the purity was estimated to be more than 95%.
Western-blot analysis verified that no proteolysis products or
oligomers were detected (results not shown).
To characterize UCP1 with spectroscopic tools, the detergent
was changed because of the strong absorption interference at low
wavelengths, attributable to the TX100 molecule. Accordingly,
TX100 was exchanged with DDM during IMAC washing steps.
DDM is a non-ionic detergent with low critical micellar concen-
tration, close to the critical micellar concentration of TX100,
and is frequently used in membrane protein crystallography.
Using our purification conditions, we were able to isolate the
DDM-exchanged UCP1–His6 at approx. 60% recovery yield and
95% purity level as shown in Figure 2(B). It is noteworthy
that the purification and recovery yields were independent of the
detergent.
Since UCP1 binds fluorescent nucleotides [27], commercially
available Mant-modified ATP was used to determine whether
our purification method affected the PN-binding conformation.
As described previously for UCP2 [28], FRET experiments re-
quiring energy transfer from the protein to the Mant-modified
nucleotide showed a probe-specific fluorescence enhancement
in the presence of UCP1–His6. As shown in Figure 3, addition
of 10 µM Mant-ATP to 5 µM of purified UCP1–His6 increased
approx. 2.5-fold the intensity of emission peak at 435 nm
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(λex = 280 nm) due to energy transfer from the protein to the
probe. Moreover, increase in the fluorescence could be displaced
by competition with 1 mM unmodified ATP. The intrinsic fluo-
rescence of 10 µM Mant-ATP in this wavelength range ex-
plained why the emission signal at 435 nm did not fully return to
its initial value in the presence of the competitor and UCP1–His6.
These results indicate that the PN-binding conformation is pro-
perly conserved after the IMAC step. Given that FRET measure-
ments have been performed with DDM-exchanged UCP1, we
also consider DDM to be suitable for further biophysical charac-
terization.
Secondary structure of UCP1–His6 by far-UV CD
CD spectroscopy was accordingly used to determine the second-
ary structure of the DDM-purified UCP1–His6 as well as the
possible conformational changes induced by the addition of an
inhibitor such as GTP. Indeed, CD analysis is known to be very
reliable when determining the α-helix content [29], the suspected
major component of UCP (and other MCF members) secondary
structures. To estimate the secondary structure from CD spectra,
we assumed that analyses of CD spectra of the membrane protein
by comparison with a CD spectrum reference set of well-solved
structures of globular proteins produced accurate results. This
point is still under debate, mainly because of peak magnitude
variations due to the nature of the protein environment [30]. This
is particularly true for hydrophobic proteins embedded in large
membrane particles, where absorption flattening and differential
scattering artifacts were observed [31,32]. In any case, differences
between helix contents estimated from the structure and from the
CD spectrum appear to be rather low for a number of membrane
proteins, including lactose permease (80% estimated [33] versus
78% calculated from the structure [34]) or nicotinic acetylcholine
receptor (23% estimated [35] versus 25.5% calculated [36,37]).
At least for a largely helical protein, α-helical elements seem to
produce a signal that is less sensitive to environment and finally
yields correct predictions, irrespective of the wavelength range
scanned during the measurement [29].
The recorded CD spectra of free and GTP-loaded UCP1–His6
are shown in Figure 4. A qualitative analysis indicated that
the spectra were dominated by the contribution of α-helices,
with prominent negative bands of similar magnitudes at 222
and 208 nm and a strong positive maximum centred at 194 nm.
Furthermore, comparison of the spectra obtained in the presence
or absence of GTP suggested that uninhibited and inhibited UCP1
conformations did not significantly differ at the level of their
secondary-structure content.
To estimate the secondary-structure content, deconvolution of
free and PN-loaded UCP1–His6 CD spectra was subsequently
performed on the basis of reference CD data set. The latter
contained CD spectra of 43 globular proteins of solved structure,
representative of α-helix, β-sheet, β-turn and unordered elements
[21]. Later, SVD calculations converged to a final solution with
or without the inhibitor. Linear combination of defined CD
spectra fitted suitably to the experimental CD measurements over
the entire wavelength range (190–240 nm). In fact, very good
normalized RMSDs, goodness-of-fit standard parameters issued
from the comparison between experimental and back-calculated
data [38], were obtained with the CDSSTR algorithm and
reflected the accurate analysis of secondary structure (normalized
RMSD <0.005 with or without GTP). It is noteworthy that both
SELCON3 and CDSSTR algorithms converged to a high helical
degree (up to 70%), but SELCON3 results were rejected due to
poorer normalized RMSD values (>0.1). Since compositions of
β-sheets, β-turns and random coils can only be estimated from
Figure 4 CD spectroscopy of highly purified UCP1–His6
CD spectra of highly purified (5 µM) UCP1–His6 were taken at room temperature in a 0.1-cm
path length cell in 5 mM Tris and 0.3 % DDM (pH 6.8) in the absence (—) or presence
(-----) of 100 µM GTP. GTP-binding equilibrium was allowed for 5 min before CD recording.
Ten scans were collected for each sample at 0.2 nm intervals from 240 to 190 nm, then averaged
and baseline-corrected by subtraction of blank buffer. CDSSTR-calculated helical contents
estimated from CD spectra were 68 and 69 % respectively in the absence and presence of GTP.
experimental data measured to 184 nm or below [29], estimation
of non-helical components was not considered as a reliable result
in regard to the wavelength range of our CD spectra.
We observed that UCP1–His6 consists of 68% of α-helix in
its free form and 69% in its GTP-loaded conformation. These
results provide the first qualitative and quantitative structural
characterization of a purified UCP subfamily member. These
measurements strongly suggest that the α-helix represents its
predominant structural component with approx. 70% of helical
degree, which is at least 25% higher than previous topological
predictions (see the Introduction section). This high helical
percentage is consistent with a model that includes six membrane-
spanning α-helices and three hydrophilic α-helices within the
matricial loop protrusions (see below). Furthermore, the binding
of GTP does not influence the helical content since CD spectra
were not significantly affected by the addition of the inhibitor.
Comparative analysis of UCP1 versus AAC1
Recently, the structure of the bovine heart AAC1 has been
determined in the carboxyatractyloside-inhibited conformation to
a 2.2 Å resolution [9]. The overall architecture can be described
as a barrel of six transmembrane α-helices, which delimits
a conical pit widely opened towards the cytosolic side. The
odd-numbered helices exhibit an average length of 32 residues
with a proline that induces a hinge at 2/3 from the N-terminus
of the helix and cranks its C-terminal end towards the inside of
the pit. The proline is located in the PX(D/E)XX(K/R) signature
sequence [39], which is strictly conserved among all mito-
chondrial carriers and defines a hinge certainly involved in the
translocation of substrates. The even helices are more hydro-
philic and are approx. 25 residues long. Parallel to the matricial
membrane surface, three hydrophilic 11-residue-long α-helices
connecting odd- and even-numbered helices strengthen the
carboxyatractyloside-inhibited conformation of the carrier. In
the carboxyatractyloside-inhibited conformation, these helically
shaped elements increase the helical degree to 66%, in contrast
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Figure 5 UCP1 repeat 1 model based on AAC1 structure
(A) Alignment between AAC1 repeat 1 and UCP1 repeat 1 was performed using ClustalW. Helices
were located on the primary sequence. (B) The model was obtained by automated homology
modelling (Swiss-Model) using AAC1 structure (1OKC, [7]) as the template. Same as in (A);
H1 and H2 are the two membrane-spanning helices of the first repeat and are connected by an
h12 hydrophilic helix located in the matricial loop. The position of the proline hinge is shown
by an arrow. AAC1 structure is shown in light grey including repeat 1 in black. UCP1 repeat 1
model is shown in dark grey.
with previous computational predictions (<40%). Similarly, our
CD results demonstrate a helical degree of approx. 70% for
solubilized UCP1–His6, which is consistent with the determined
α-helix content of the AAC1.
We generated the comparative model of UCP1 using the AAC1
structure as the template. Comparative modelling or homology
modelling is a computational procedure by which a three-
dimensional model of a target protein, in fact a target primary
sequence, is built on the basis of the structure of an X-ray-resolved
homologue protein. As shown in Figure 5, only the repeat 1 se-
quence of UCP1 was modelled for two reasons: (i) only repeat 1
of UCP1 is suitably aligned on repeat 1 of the AAC1 with
27% homology and only two gaps; and (ii) since UCP1 has
no carboxyatractyloside-inhibited conformation, we could not
produce a realistic model of the entire structure of UCP1 on the
basis of AAC1. With regard to the homology between repeat 1 se-
quences of UCP1 and AAC1, Swiss-Model was able to produce a
model of the UCP1 first domain that fitted suitably on AAC1
repeat 1 (α-carbon RMSD of 0.17 Å). The overall structural fold
contained three helices, i.e. two transmembrane helices H1 (N-
terminus) and H2 (C-terminus) connected by a loop that included a
small helix (h12) parallel to the membrane surface. The hinged H1
described for odd-numbered helices in AAC1 was also observed
in UCP1 at the conserved proline level. Therefore we deduced
the secondary-structure content from the obtained model: UCP1
repeat 1 model exhibited 68% of helically shaped elements. Thus
according to internal sequence homology of the repeats of UCP1
and AAC1, this estimation agrees with our CD quantification.
Conclusions
To summarize, we found quantitative evidence that α-helix is the
major component of UCP1 secondary structure. Moreover,
the PN-binding mechanism does not involve defined secondary-
structure rearrangement as reflected by the helical content con-
servation in free and GTP-loaded UCP1 conformations. For
secondary structure (experimental and computational data) and
proline signature sequence conservation, we hypothesize that the
UCP1 structure is very similar to the AAC. Long, cranked odd-
numbered helices including proline hinges as well as membrane-
parallel hydrophilic helices could be common features of both
AAC and UCP.
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